Objective

To gain insight into ways to build trust in precision medicine. A lack of trust can be considered a risk in the development of precision medicine. To better understand such a risk several questions need to be explored:

  • In the era of big data and precision medicine, what is trust?
  • In contrast to trust, what is ‘trustworthiness’? And ‘confidence’?
  • What are the risks if trust is lacking or incomplete?
  • Could novel technologies help build trust?
  • What is the role of the medical sector?
  • What is the role of industry?
  • Can trust be measured? Can it be mandated?

Audience

Around 30 experts from various disciplines and countries, including research, policy, regulation, and industry.

Organising committee

Prof. Effy Vayena, Marie-Valentine Florin, Isabella Beretta, Dr Gérard Escher, Prof. Jacques Fellay, Prof. Samia Hurst-Majno, Dr Adrien Lawrence